Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Toxins
|
January 23, 2015
Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury
Caitlin S L Parello, Chad L Mayer, Benjamin C Lee, et al.
Frontiers in Immunology
|
April 24, 2015
Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns
Chad L Mayer, Caitlin S L Parello, Benjamin C Lee, et al.
Physiological Reviews
|
August 1, 2013
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding
Kendra N Iskander, Marcin F Osuchowski, Deborah J Stearns-Kurosawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2012
Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax
Chandra C Ghosh, Aditi Mukherjee, Sascha David, et al.
Shock (Augusta, Ga.)
|
July 17, 2003
Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide
Toshihiro Kaneko, D J Stearns-Kurosawa, Fletcher Taylor, et al.
Gynecologic Oncology
|
June 29, 2007
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study
D Scott McMeekin, Michael W Sill, Kathleen M Darcy, et al.
Shock (Augusta, Ga.)
|
August 1, 2006
Proteinase 3 expression on neutrophil membranes from patients with infectious disease
Takeshi Matsumoto, Toshihiro Kaneko, Hideo Wada, et al.
Pediatric Nephrology (Berlin, Germany)
|
May 24, 2011
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide
Deborah J Stearns-Kurosawa, Valta Collins, Scott Freeman, et al.
Gynecologic Oncology
|
February 20, 2007
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Doris Benbrook, et al.
Blood
|
January 10, 2002
Plasma levels of endothelial protein C receptor respond to anticoagulant treatment
Deborah J Stearns-Kurosawa, Kandice Swindle, Armando D'Angelo, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Toxins
|
January 23, 2015
Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury
Caitlin S L Parello, Chad L Mayer, Benjamin C Lee, et al.
Frontiers in Immunology
|
April 24, 2015
Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns
Chad L Mayer, Caitlin S L Parello, Benjamin C Lee, et al.
Physiological Reviews
|
August 1, 2013
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding
Kendra N Iskander, Marcin F Osuchowski, Deborah J Stearns-Kurosawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2012
Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax
Chandra C Ghosh, Aditi Mukherjee, Sascha David, et al.
Shock (Augusta, Ga.)
|
July 17, 2003
Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide
Toshihiro Kaneko, D J Stearns-Kurosawa, Fletcher Taylor, et al.
Gynecologic Oncology
|
June 29, 2007
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study
D Scott McMeekin, Michael W Sill, Kathleen M Darcy, et al.
Shock (Augusta, Ga.)
|
August 1, 2006
Proteinase 3 expression on neutrophil membranes from patients with infectious disease
Takeshi Matsumoto, Toshihiro Kaneko, Hideo Wada, et al.
Pediatric Nephrology (Berlin, Germany)
|
May 24, 2011
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide
Deborah J Stearns-Kurosawa, Valta Collins, Scott Freeman, et al.
Gynecologic Oncology
|
February 20, 2007
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Doris Benbrook, et al.
Blood
|
January 10, 2002
Plasma levels of endothelial protein C receptor respond to anticoagulant treatment
Deborah J Stearns-Kurosawa, Kandice Swindle, Armando D'Angelo, et al.
Page
of 7